AI echocardiogram model could speed cardiac amyloid diagnosis, expanding access in underserved settings.
Expert Interviews
Dr. Kohli highlights the benefits of early, sustained LDL lowering for greater cardiovascular risk reduction and prevention.
Non-statin therapies key for high-risk patients not at LDL goal, says Dr. Kohli; advocates broader risk assessment.
Aldosterone may be the hidden culprit in hard-to-treat hypertension, offering new hope for targeted therapies.
Deepak Bhatt, MD, discusses EMPACT-MI findings on empagliflozin’s kidney safety and heart failure benefits after ACS.
AI-powered cardiac MRI shows how aging impacts heart structure—and reveals hidden risks from common conditions.
Black patients face higher amputation risk from PAD due to late CLTI care and limited access to revascularization.
ESC 2025: Acoramidis may reduce AF/flutter burden in ATTR-CM, per new ATTRibute-CM trial analysis discussed by CardioNerds.
BMAL1-HIF2α link explains why AM heart attacks hit harder—new findings may lead to time-based cardioprotective therapies.
AI-driven ECGs are transforming heart failure care—enabling early detection, cutting costs, and expanding access.
Dr. Payal Kohli dives into new tech and AI reshaping how we diagnose and manage hypertension.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.